3/31
04:12 pm
zvra
Zevra Therapeutics Files Preliminary Proxy
Low
Report
Zevra Therapeutics Files Preliminary Proxy
3/18
01:13 pm
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) was given a new $18.00 price target on by analysts at JMP Securities.
Medium
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) was given a new $18.00 price target on by analysts at JMP Securities.
3/13
12:36 pm
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $23.00 to $25.00. They now have a "buy" rating on the stock.
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $23.00 to $25.00. They now have a "buy" rating on the stock.
3/13
11:43 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its price target raised by analysts at Guggenheim from $20.00 to $22.00. They now have a "buy" rating on the stock.
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its price target raised by analysts at Guggenheim from $20.00 to $22.00. They now have a "buy" rating on the stock.
3/13
08:00 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
3/12
10:33 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $25.00 price target on the stock.
Medium
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $25.00 price target on the stock.
3/12
09:12 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "outperform" rating re-affirmed by analysts at Citigroup Inc..
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "outperform" rating re-affirmed by analysts at Citigroup Inc..
3/11
04:54 pm
zvra
Zevra Reports Full Year 2024 and Fourth Quarter Financial Results [Yahoo! Finance]
Low
Report
Zevra Reports Full Year 2024 and Fourth Quarter Financial Results [Yahoo! Finance]
3/11
04:05 pm
zvra
Zevra Reports Full Year 2024 and Fourth Quarter Financial Results
Low
Report
Zevra Reports Full Year 2024 and Fourth Quarter Financial Results
2/28
08:54 am
zvra
Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read Between the Signs,' to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C [Yahoo! Finance]
Low
Report
Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read Between the Signs,' to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C [Yahoo! Finance]
2/28
07:30 am
zvra
Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read Between the Signs,’ to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C
Low
Report
Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read Between the Signs,’ to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C
2/27
07:30 am
zvra
Zevra Therapeutics Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million
Medium
Report
Zevra Therapeutics Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million
2/26
09:46 am
zvra
Zevra to Report 2024 Fourth Quarter and Full Year Financial Results
Low
Report
Zevra to Report 2024 Fourth Quarter and Full Year Financial Results
2/24
04:02 pm
zvra
Zevra to Participate at Upcoming Investor Conferences
Low
Report
Zevra to Participate at Upcoming Investor Conferences
2/22
03:30 pm
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) was given a new $21.00 price target on by analysts at Guggenheim.
Medium
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) was given a new $21.00 price target on by analysts at Guggenheim.
1/30
08:36 am
zvra
Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™ [Yahoo! Finance]
Low
Report
Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™ [Yahoo! Finance]
1/30
07:30 am
zvra
Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™
Low
Report
Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™
1/30
07:28 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
1/29
04:05 pm
zvra
Zevra Therapeutics to Participate at Upcoming Investor Conferences
Low
Report
Zevra Therapeutics to Participate at Upcoming Investor Conferences
1/8
11:20 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $25.00 price target on the stock.
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $25.00 price target on the stock.